Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision label now reads v3.6.5, replacing the previous v3.6.4.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedUpdated the page revision tag from v3.6.3 to v3.6.4, indicating an internal site update. The change represents maintenance or enhancements to the underlying platform rather than to the study details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a software version update of the page rather than a change to trial content.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page shows a revision from v3.6.0 to v3.6.2. This appears to be a minor update to the ClinicalTrials.gov page, likely including small fixes or UI tweaks without changing study details.SummaryDifference0.1%

- Check59 days agoChange DetectedRecruitment status is updated to indicate no further participant enrollment. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, and the Intervention/Treatment label is updated while older labels and revision text are removed.SummaryDifference0.5%

- Check66 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a minor update to the page version. No substantive study information appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.